Wang, L., Shang, X., & Feng, Q. (2018). LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis. Cancer Biol Ther.
Chicago Style CitationWang, Linmei, Xueqin Shang, and Qingqing Feng. "LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis." Cancer Biol Ther 2018.
MLA CitationWang, Linmei, Xueqin Shang, and Qingqing Feng. "LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis." Cancer Biol Ther 2018.
Warning: These citations may not always be 100% accurate.